Dr. Reddy's Laboratories Ltd (RDY) - 16 Year Stock Split History

Historical stock splits for Dr. Reddy's Laboratories Ltd since 2001. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $6.244B $2.171B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection